 |
|
Drug could improve pregnancy outcomes in wider range of women with insulin resistance
September 07, 2007Women who are obese, have type 2 diabetes or a family history of type 2 diabetes could one day have more successful pregnancies because of a study at Washington University School of Medicine in St. Louis.
This study, performed in mice, suggests that Metformin, the most commonly prescribed anti-diabetes drug, could potentially improve pregnancy outcomes in women with insulin resistance.
"We found that embryos of insulin-resistant mice also have some degree of insulin resistance, and if we correct the insulin resistance in the embryo with this drug, we improve the quality of the embryo," says Kelle Moley, M.D., lead author and professor of obstetrics and gynecology.
The finding, published online in Diabetes, suggests that Metformin could benefit women with type 2 diabetes or polycystic ovary syndrome (PCOS). About 8 percent of women trying to conceive have insulin resistance, Moley says, and even more are suspected to be borderline. In some cases, a family history of type 2 diabetes or being overweight may be the only indication that the patient may be prone to insulin resistance.
Metformin is often given to women with PCOS, an endocrine disorder that affects insulin and results in higher rates of miscarriage. These women often share the same pregnancy complications as women with type 2 diabetes and obesity.
Recent studies have shown that metformin not only aids conception in women with PCOS but also reduces the high miscarriage rates; however, how the drug does this has been unclear.
Using early-stage mouse embryos, Moley and her colleagues showed for the first time that metformin improves insulin action in insulin-resistant embryos. That allowed the embryos to absorb glucose, an important energy source, and prevented the death of cells in the embryos. As a result, the embryos were more likely to successfully implant in the uterus and to continue growing.
Moley's group also identified the molecular mechanism that accounts for metformin's positive effects. They found the drug triggers an important sensor of the energy level of cells, which sets off a chain of reactions that help insulin do its job. Previously it was not known that this sensor molecule was active in early embryos.
Moley hypothesizes that in insulin-resistant women, high levels of insulin and related factors cause their embryos to compensate by shutting down insulin signaling mechanisms. That impairs the early embryo's ability to take in glucose at a critical stage of development and can lead to pregnancy failure.
"We found that Metformin improves glucose uptake and improves the survival of the early embryo as a result," Moley says. "Mouse embryos in a high-insulin environment that were not exposed to Metformin did not survive."
Most miscarriages are due to chromosomal abnormalities. But Moley says this study provides new scientific evidence that miscarriages related to insulin resistance possibly could be avoided through the use of metformin.
"This will help physicians know better how to treat these women and reassure them that they're being correctly treated for their medical problems and that their babies will benefit from that treatment," she says.
Washington University School of Medicine
The finding, published online in Diabetes, suggests that Metformin could benefit women with type 2 diabetes or polycystic ovary syndrome (PCOS). About 8 percent of women trying to conceive have insulin resistance, Moley says, and even more are suspected to be borderline. In some cases, a family history of type 2 diabetes or being overweight may be the only indication that the patient may be prone to insulin resistance.
Metformin is often given to women with PCOS, an endocrine disorder that affects insulin and results in higher rates of miscarriage. These women often share the same pregnancy complications as women with type 2 diabetes and obesity.
Recent studies have shown that metformin not only aids conception in women with PCOS but also reduces the high miscarriage rates; however, how the drug does this has been unclear.
Using early-stage mouse embryos, Moley and her colleagues showed for the first time that metformin improves insulin action in insulin-resistant embryos. That allowed the embryos to absorb glucose, an important energy source, and prevented the death of cells in the embryos. As a result, the embryos were more likely to successfully implant in the uterus and to continue growing.
Moley's group also identified the molecular mechanism that accounts for metformin's positive effects. They found the drug triggers an important sensor of the energy level of cells, which sets off a chain of reactions that help insulin do its job. Previously it was not known that this sensor molecule was active in early embryos.
Moley hypothesizes that in insulin-resistant women, high levels of insulin and related factors cause their embryos to compensate by shutting down insulin signaling mechanisms. That impairs the early embryo's ability to take in glucose at a critical stage of development and can lead to pregnancy failure.
"We found that Metformin improves glucose uptake and improves the survival of the early embryo as a result," Moley says. "Mouse embryos in a high-insulin environment that were not exposed to Metformin did not survive."
Most miscarriages are due to chromosomal abnormalities. But Moley says this study provides new scientific evidence that miscarriages related to insulin resistance possibly could be avoided through the use of metformin.
"This will help physicians know better how to treat these women and reassure them that they're being correctly treated for their medical problems and that their babies will benefit from that treatment," she says.
Washington University School of Medicine
Insulin Current Events and Insulin News RSSScripps research scientists find new link between insulin and core body temperature
A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature.
Scientists find molecular trigger that helps prevent aging and disease
Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease?
Fat collections linked to decreased heart function
Researchers from Boston University School of Medicine (BUSM) have shown that fat collection in different body locations, such as around the heart and the aorta and within the liver, are associated with certain decreased heart functions.
Researchers discover mechanism of insulin production that can lead to better treatment for diabetes
How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities.
Curry-cure? Spicing up the effectiveness of a potential disease-fighter
Scientists are reporting development of a nano-size capsule that boosts the body's uptake of curcumin, an ingredient in yellow curry now being evaluated in clinical trials for treatment of several diseases.
Postmenopausal women with higher testosterone levels
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels.
New scientific study indicates that eating quickly is associated with overeating
According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), eating a meal quickly, as compared to slowly, curtails the release of hormones in the gut that induce feelings of being full.
AAP supports the IDF guideline on oral health for people with diabetes
New clinical guidelines released by the International Diabetes Foundation (IDF) emphasize the importance of periodontal health for people with diabetes.
Study: Lap band surgery effective for morbidly obese children
A surgeon at Children's National Medical Center and his colleagues from New York University have found laparoscopic adjustable gastric banding (Lap band) to improve the health of morbidly obese adolescents.
UM Scientists Create Fruit Fly Model to Help Unravel Genetics of Human Diabetes
As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis.
More Insulin Current Events and Insulin News Articles
 |
The Insulin-Resistance Diet--Revised and Updated: How to Turn Off Your Body's Fat-Making Machine by Cheryle Hart (Author), Mary Kay Grossman (Author) Conquer insulin resistance. Reduce cravings. Eat your favorite foods. And lose weight! If you have tried every diet and are still struggling with your weight, the real culprit may be insulin resistance. When you have more glucose than your body needs, your body responds by producing more insulin to stabilize your blood sugar level and store the excess glucose as fat. In The Insulin-Resistance Diet, Cheryle R. Hart and Mary Kay Grossman show you how to control insulin resistance and lose weight without sacrificing all of your favorite foods. Overcome insulin resistance and lose weight with: The exclusive Link-and-Balance Eating Method, which balances carbs with the right amount of protein at the right time for maximum weight loss Self-tests to... |
 |
EasyTouch Insulin Syringe 28 Gauge, 1cc, 1/2", 100 Count by Masters Healthcare We apologize, but this product will no longer be offered at HealthWarehouse.com. A comparable syringe is located HERE.. 12.7mm needle. For 100 units or less. Film coated for maximum comfort. 100% latex free. Special surgical grade stainless steel.. |
 |
Using Insulin, Everything You Need for Success With Insulin by John Walsh (Author), Ruth Roberts (Author), Timothy Bailey (Author), Chandra B. Varma (Author) |
 |
Diabetic Cooler & Organizer Penplus Wallet by Medicool This Oranizer will keep insulin pen delivery systems and vials cool For Vials or Pens with the re-freezable cold gel pack which keeps insulin cool for up to 12 hours in 100 degree heat. The unit organizes all of your required diabetic supplies, including your meter, in a variety of pockets and storage compartments which are neatly insulated to avoid condensation contamination. The attached hand strap and belt loop make transportation seemingly effortless. The organizer can also easily fit into a medium sized purse. Can be worn on your belt The organizer is constructed of durable nylon, is water resistant and comes in black. Supplies not included Size: 8 x 4 3/4 x 2 7/8 When used with the Refreezable Gel Pack the PenPlus Case can hold up to four vials of insulin or two insulin... |
 |
U-40 Insulin Syringe 1/2cc (100 pack) Medium Dose 29 Gauge 1/2" by Ulti Med, Inc. UltiCare Ulti-Fine 28 Gauge Insulin Syringe. (100 Pack)1/2cc - 29 gauge x 1/2"U-40 Insulin (.5 ml - .33mm x 12.7mm)Instructions for Use:To expose plunger, remove large cap. To expose needle, pull small red cap STRAIGHT off, being careful not to bend the needle. To measure correct dosage, align top edge of plunger tip with your dosage mark on the syringe scale. Use a syringe ONCE only. To prevent misuse after injection, dispose syringe in a sealable puncture proof container. By Ulti Med, Inc. |
 |
The Discovery of Insulin: Twenty-fifth Anniversary Edition by Michael Bliss (Author) When insulin was discovered in the early 1920s, even jaded professionals marveled at how it brought starved, sometimes comatose diabetics back to life. In this now-classic study, Michael Bliss unearths a wealth of material, ranging from scientists’ unpublished memoirs to the confidential appraisals of insulin by members of the Nobel Committee. He also resolves a longstanding controversy dating to the awarding of the Nobel to F. G. Banting and J. J. R. Macleod for their work on insulin: because each insisted on sharing the credit with an additional associate, medical opinion was intensely divided over the allotment of credit for the discovery. Bliss also offers a wealth of new detail on such subjects as the treatment of diabetes before insulin and the... |
 |
Insulow Dietary Supplement, Capsules, 180-Count Bottle by Insulow Insulow, recommended in Diabetes Solutions by Dr. R. Bernstein, is pure R+ Lipoic acid complexed with essential Biotin. R+ lipoic enhances glucose uptake and insulin sensitivity which reduces insulin spike after carbohydrate containing meals. Improving carbohydrate uptake and utilization can increase energy levels and improve your ability to use both fat and carbohydrates for energy. |
 |
Medport Diabetes Travel Organizer From GMS Holds Two Weeks Supplies/ Will Hold Syringes,vials Pens Secure(well Constructed ,One of the Nicest Diabetic Travel Bags on the Market) a Great Value - Cools for up to 18 Hrs Comes with 2-6 Oz Polar Tech Gel Paks by Medport Holds enough supplies for up to two weeks. Cool side carries insulin and MED IceTM. Room temperature side carries meter and supplies. Detachable medical waste pouch provides a safe alternative to store medical waste until properly disposed. Convenient handy carry strap. Includes two MED IceTM refreezable ice packs. Measures 9 in. x 6 in. x . This item only available in black. |
 |
Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin by M.S. Gary Scheiner M.S. (Author), Ph.D. Barry Goldstein M.D. M.D. (Foreword) Dozens of books offer advice on managing diabetes, but few focus specifically on the day-to-day issues facing those who use insulin. Now Gary Scheiner, a certified diabetes educator and himself an insulin user himself since 1985, gives you the tools to "think like a pancreas"--that is, to successfully master the art and science of matching insulin to the body’s ever-changing needs. Free of medical mumbo jumbo, comprehensive, and packed with useful information not readily available in other books, Think Like a Pancreas discusses: • day-to-day blood glucose control and monitoring |
 |
Syringe Magnifier (connects on the side of the syringe)Fits All 1cc and 1/2cc Insulin Syringes by Ezy Dose Don't risk your health by allowing them to give the wrong dosage to themselves. You can avoid dosage errors with the Syringe Magnifier. Our Syringe Magnifier easily clips to your syringe making the calibrations easy to see and read. The Syringe Magnifier works on either 1 cc or 1/2 cc insulin syringes. |
| © 2009 BrightSurf.com |